financetom
Business
financetom
/
Business
/
Westlake's PEM Earnings at Trough, Gradual Recovery Expected in 2025, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Westlake's PEM Earnings at Trough, Gradual Recovery Expected in 2025, RBC Says
Aug 29, 2024 3:05 AM

09:28 AM EDT, 08/23/2024 (MT Newswires) -- Westlake (WLK) is at a low point in its performance and essential materials, or PEM, earnings cycle, but a gradual recovery is expected in 2025, driven by improved caustic earnings and better demand trends, RBC said in a note Friday.

"[Westlake] is seeing weak market conditions across chlorovinyls, with slower demand growth post-COVID in Asia" and rising raw material costs could be headwinds, RBC said in the note.

RBC said it expects potential future rate cuts to boost demand in the building and construction, or B&C, aiding both PEM and housing and infrastructure products, or HIP, segments.

"HIP could accelerate outperformance from rate cuts. Currently, HIP is benefiting from low input costs from PEM," RBC said.

RBC upgraded Westlake's stock to outperform from sector perform and lifted the price target to $174 from $157.

Price: 146.50, Change: +1.92, Percent Change: +1.33

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Peloton Names Peter Stern CEO, President
Peloton Names Peter Stern CEO, President
Oct 31, 2024
07:31 AM EDT, 10/31/2024 (MT Newswires) -- Peloton Interactive ( PTON ) said Thursday that Peter Stern has been appointed as its chief executive officer and president, starting Jan. 1, 2025. Stern currently serves as president of Ford Motor's ( F ) Ford Integrated Services, Peloton said. ...
Regeneron beats results estimates on demand for eczema treatment, eye drug
Regeneron beats results estimates on demand for eczema treatment, eye drug
Oct 31, 2024
(Reuters) - U.S. drugmaker Regeneron Pharmaceuticals ( REGN ) beat Wall Street estimates for third-quarter profit and revenue on Thursday, driven by strong demand for its eczema treatment Dupixent and blockbuster eye disease drug Eylea. Regeneron has been looking to upgrade patients who use Eylea to a high-dose version, as the drug that has long been its cash cow faces...
NetApp Insider Sold Shares Worth $1,071,929, According to a Recent SEC Filing
NetApp Insider Sold Shares Worth $1,071,929, According to a Recent SEC Filing
Oct 31, 2024
03:13 AM EDT, 10/24/2024 (MT Newswires) -- George Kurian, Director, Chief Executive Officer, on October 21, 2024, sold 8,500 shares in NetApp ( NTAP ) for $1,071,929. Following the Form 4 filing with the SEC, Kurian has control over a total of 292,778 shares of the company, with 292,778 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1002047/000095017024116773/xslF345X05/ownership.xml ...
Engie to provide Meta with 260 MW of renewable energy from US solar plant
Engie to provide Meta with 260 MW of renewable energy from US solar plant
Oct 31, 2024
Oct 31 (Reuters) - Engie has signed a deal with Facebook owner Meta Platforms ( META ) for the U.S. social media group to buy 100% of the output from its U.S. Sypert solar power plant, the French utility said on Thursday. The plant is expected to start operating in late 2025, Engie said. Once operational, it will add to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved